Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection
Status:
Terminated
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
This Phase III trial four treatment strategies non-critically ill hospitalized participants
(not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection,
Participants will receive hydroxychloroquine or chloroquine with or without azithromycin.